The host of the webinar, Professor Lavanya Nandan, who is the director principal at Nightingale Hospital and a member of the nursing forum at Uttar Pradesh Noida, then introduced the second speaker, Dr. Sharon, an education executive at Life Healthcare, South Africa. Dr. Sharon’s impressive background in nursing education, leadership, and quality assurance, along with her passion for people development and coaching, made her a valuable addition to the webinar.

Dr. Sharon was welcomed by the audience, which consisted of nursing educators, students, and young nurses interested in exploring opportunities overseas. She thanked everyone for their attendance and acknowledged the need to upgrade the standards of the nursing profession in India. Dr. Sharon mentioned that the government had recently sanctioned 157 nursing colleges in the budget to improve infrastructure and teaching quality. However, the profession was at a crossroad, with some private institutions performing well and others struggling to keep up.

Dr. Singh then took the floor and spoke about the current state of the nursing profession in India. He noted that the commitment of Florence Nightingale needed to be compensated and that the nursing profession was going to take the back seat, even in India. Dr. Singh emphasized the need for nurses, especially in high-risk jobs that require working day and night. He also discussed the importance of the nursing forum, a not-for-profit initiative launched a few months ago to benefit its members through training programs and a magazine that reaches 97,000 people.

Dr. Sharon and Dr. Singh then interacted with the audience and answered questions on a variety of topics related to nursing education, job opportunities, and the challenges faced by nurses in India. 

Overall, the webinar provided valuable insights into the current state of the nursing profession in India and the opportunities available for nurses interested in exploring overseas opportunities. The expert speakers shared their knowledge and experience, and the audience engaged in a lively discussion, making the webinar a success.

Another critical factor to consider before working abroad is understanding the requirements of the country you plan to work in. Different countries have different requirements for foreign workers, and it’s essential to know what documents and certifications one need before a person can work in foreign lands legally. One need to ensure that the education and training meet the country’s standards and they have the necessary licenses and certifications.

Language proficiency is another crucial factor to consider before working abroad. Most countries have a national language that you need to be proficient in to work effectively. If you are not fluent in the language, you may need to take language courses to improve your proficiency. It’s also essential to consider the cultural differences and how they may affect your work and interactions with colleagues and patients.

Career progression is another factor that you should consider before working abroad. It’s essential to have a clear understanding of how your career will progress and whether there will be opportunities for growth and advancement in the country you plan to work in. You also need to consider the long-term impact of working abroad on your career when you eventually return home.

Discussing the move with your family is also essential before working abroad. It’s essential to consider how the move will affect your family and their quality of life. You need to discuss your plans with your family and ensure that they are supportive of your decision.

Working abroad can provide opportunities for international travel and work, but it’s essential to consider the big decision it entails. You need to prepare and complete a lot of forms and not get impatient during the process. Lastly, it’s essential to learn about visas and work permits before working in another country.

In conclusion, working abroad can be an exciting and rewarding experience, but it’s important to consider several factors before making the big decision. Understanding the requirements of the country you plan to work in, language proficiency, career progression, discussing the move with your family, and learning about visas and work permits are some of the factors to consider. It’s crucial to do your research and seek advice from those who have already made the move to ensure a successful transition to working abroad.

In addition to the requirements and processes outlined for nurses looking to practice in Canada, New Zealand, the United Kingdom, and the United States, there are some general tips that can help international nurses navigate the process more smoothly. Firstly, it’s important to start the process as early as possible to allow time for any delays or issues that may arise. You should also ensure that you have all necessary documents and paperwork in order, such as your passport, educational transcripts, and work experience certificates. It’s also a good idea to research the culture and healthcare system of the country you’re interested in working in to better understand the expectations and standards of nursing practice. Networking and connecting with other nurses who have gone through the registration process in the same country can also be helpful in providing advice and guidance.

Furthermore, it’s important for nurses to have a good understanding of the language used in the country they wish to work in. For example, in Canada and the United States, English is the primary language, while in Quebec and parts of New Brunswick, French is also widely spoken. In New Zealand, Maori is an official language, and many healthcare settings require a basic understanding of the language and culture. In the United Kingdom, English is the primary language, but there are also opportunities to work in Welsh-speaking areas.

Lastly, it’s important for nurses to be aware of the differences in nursing practice and healthcare systems between their home country and the country they wish to work in. Each country has its own unique approach to healthcare, and nurses should be prepared to adapt to new ways of working and caring for patients. This may involve learning new procedures and protocols, working with different types of equipment, and understanding the cultural expectations of patients and colleagues.

Dr. Sharon, discussed the benefits of working abroad as a nurse, including the opportunity to study and practice nursing in a foreign country, and the support provided by many companies for foreign nurses. Dr. Sharon emphasizes the importance of settling down before bringing family members and highlights that international nurses are often treated well by employers, sometimes even provided accommodation. She encourages pursuing further studies and having original documents ready.

In response to a question, Dr. Sharon notes that it is possible to get a job as a psychiatric nurse with the right qualifications and experience. She also mentions that taking the in clicks exam multiple times is possible, but requires a fee each time. When it comes to studying nursing abroad, specific requirements may vary depending on the country and institution, such as language proficiency exams and standardized tests like the GRE or TOEFL.

Dr. Sharon briefly mentions that Japan and Germany are countries that are open to nurses from Asian countries, such as India. However, she indicates that she does not know much about the future in South Korea, as the discussion in the video focuses more on the countries that participants are more interested in.

In conclusion, becoming a registered nurse in a foreign country can be a challenging but rewarding experience. It requires dedication, hard work, and a willingness to adapt to new environments and cultures. However, the opportunities for career advancement, personal growth, and cultural exchange make it an attractive option for many nurses looking to expand their horizons. By following the specific requirements and processes for the country they wish to work in, international nurses can achieve their goal of practicing nursing abroad and making a positive impact on the healthcare system and patients they serve.

Overall, the webinar provided valuable insights for nurses considering working abroad, including the benefits, preparation, and requirements. Dr. Sharon’s experience and advice can be helpful for those seeking to launch an international nursing career.

The webinar concluded with the announcement of an upcoming international conference, “Innovation in Health, No Health,” which would feature a panel discussion exclusively for nurses. Dr. Sharon promised to write for the forum’s magazine, and Dr. Singh expressed his gratitude to Dr. Sharon for her time and commitment to the nursing profession.

The post International opportunities and safeguards for Indian nurses appeared first on InnoHEALTH magazine.

The Health Ministry has also initiated a joint action plan with the Ministry of Tribal Affairs for malaria elimination in tribal areas. Malaria will soon become a notifiable disease across India, with states like Bihar, Andaman and Nicobar Islands and Meghalaya are also in the process of putting this vector-borne disease in the category. Following this, it will be required by law that cases be reported to government authorities, a report in the Hindu stated.

Currently, malaria is a notifiable disease in 33 states and union territories in India. A senior Health Ministry official said this is part of India’s vision to be malaria-free by 2027 and to eliminate the disease by 2030. The Health Ministry has also initiated a joint action plan with the Ministry of Tribal Affairs for malaria elimination in tribal areas, the report said.

India is one of the countries that endorsed the malaria elimination roadmap of the Asia-Pacific Leaders Alliance at the East Asia Summit in 2015, which galvanised the region in striving to become malaria free by 2030. India has made tremendous progress in its malaria elimination journey — observing a reduction of nearly 66 per cent in its official malaria burden between 2018 and 2022. 

Malaria is a potentially life-threatening disease caused by parasites that are transmitted through the bite of infected female Anopheles mosquitoes. Mansukh Mandaviya, Union Minister for Health & Family Welfare, said that India has witnessed 85.1 per cent decline in malaria cases and 83.36 per cent decline in deaths during 2015-2022. 

“Malaria is not just a public health issue but also a social, economic and political challenge that requires the co-operation of all stakeholders. India was the only high-burden, high-impact country in South- East Asia region to report a decline in malaria cases in 2020 as compared to 2019. India witnessed 85.1 per cent decline in malaria cases and 83.36 per cent decline in deaths during 2015-2022,” Mandaviya said. 

He added: “Rejuvenated political commitment and strengthened technical leadership will play a monumental role in eradicating malaria from the world. India is committed to sharing our resources, knowledge and learnings with other countries in our endeavour to eliminate Malaria.”  

Union health secretary Rajesh Bhushan said that awareness, detection, diagnosis and treatment need to be taken to the doorstep of the last mile community for the successful elimination of the disease. 

SOURCE: Business today

The post World Malaria Day: Malaria will soon become a notifiable disease across India, says report appeared first on InnoHEALTH magazine.

Children with multisystem inflammatory syndrome (MIS-C), a rare condition linked with the virus that causes COVID-19 have biochemical indicators of cell injury and cell death that are distinct from other children with COVID-19, according to a study funded by the National Institutes of Health. Using high speed, artificial intelligence-controlled molecular sequencing of blood-and-plasma RNA and plasma DNA, researchers found that children with MIS-C have biomarkers indicating damage to multiple organs, the lining of blood vessels and the nervous system. MIS-C usually occurs two to six weeks after SARS-CoV-2 infection, resulting in inflammation of the heart, lungs, kidneys, brain, skin, eyes or gastrointestinal tract.

To conduct the study, researchers analysed 416 blood samples from 237 patients. Their analysis enabled them to distinguish between patients with MIS-C and COVID-19. They believe their findings could lead to the development of tests that allow clinicians to distinguish between MIS-C and other conditions involving widespread inflammation, such as Kawasaki disease, septic shock, and severe COVID-19, and to the development of more appropriate treatments for each.

The study was conducted by Charles Y. Chiu, M.D., of the University of California, San Francisco, and colleagues at several other institutions. It was funded by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and appears in Cell Reports Medicine.

Source:EH News Bureau

The post Biomarker pattern found in kids with COVID 19-linked inflammatory syndrome appeared first on InnoHEALTH magazine.

• Glioblastoma is a form of brain cancer that has very low survivability rates. 
• This is partly due to the fact that glioblastoma cancers evade detection by the immune system, and spread aggressively. 
• Many recent improvements in cancer survivability rates are due to the use of immunotherapies, but it is difficult for these to cross the blood-brain barrier to treat brain cancer. 
• Researchers have now created a gel that can be injected into the tumor cavity left following surgery. The gel, which contains immunotherapies to help the immune system to kill any remaining cancer cells, was tested in mice. 

Though cancer death rates are improving overall, there are still some cancers that have poor survivability. One of those cancers is glioblastoma, a type of brain cancer that affects astrocyte cells in the brain. 

Dr. Aung Bajaj, a medical oncologist and hematologist with Arizona Oncology, not involved in this study told Medical News Today that “glioblastoma multiforme is considered the most aggressive type of brain tumor, and patients who are diagnosed with glioblastoma multiforme typically live around 1-2 years.”

“It is treated with surgical resection followed by a combination of radiation and chemotherapy. If the cancer is maximally resected, the prognosis tends to be better. However, maximum resection is not always possible due to its infiltrative properties, where glioblastoma multiforme coexists with normal brain tissue, and extensive surgery for complete removal could compromise a patient’s neurologic function,” he noted. Getting chemotherapies into the brain is challenging because of the blood-brain barrier, which prevents molecules over a certain size from reaching the brain.

One form of therapy given for glioblastoma is Gliadel wafers, which are small patches that slowly release a form of chemotherapy into the cavity left behind by the surgery, bypassing the problem posed by the blood-brain barrier.  Immunotherapies have greatly improved cancer survival rates for many other types of cancer, but the blood-brain barrier has made it challenging to replicate this success for brain cancer, explains Dr. Bajaj: “Blood-brain barrier limits the passage of therapeutic drugs crossing into the brain. Therefore, designing immunotherapy or anti-neoplastic molecules that effectively cross the blood-brain barrier has been difficult.”

In a recent study led by Dr. Honggang Cui, an associate professor from Johns Hopkins University, researchers showed that a type of gel they had developed containing immunotherapy agents improved survivability in mouse models. The study findings appear in Proceedings of the National Academy of Sciences

Source: Medical News Today

The post Immunotherapy-containing gel injected in the brain halts aggressive cancer in mice appeared first on InnoHEALTH magazine.

During the planning of our InnoHEALTH 2022 conference, an event focused on innovative solutions in healthcare, we decided to integrate CHATGPT as a panelist. With questions prepared in advance, we put CHATGPT to the test. Impressively, the AI provided answers that were as satisfactory as those from human panelists. Personally, I would place the quality of CHATGPT’s responses in the 90th percentile.

However, CHATGPT does have limitations. For instance, it struggles with questions related to real-time information or news beyond September 2021, as its training data only extends to that point. One of our session moderators highlighted this shortcoming by asking CHATGPT to predict the weather in Delhi, which it could not do.

Originally built on the GPT-3 model (the third version of OpenAI’s Generative Pre-trained Transformer), CHATGPT now offers access to the more advanced GPT-4 model through a $20 per month subscription. Intrigued by its potential, I upgraded my account in hopes of utilizing CHATGPT for my consulting work, which involves editing and contributing to extensive reports for international clients.

Upon upgrading my account, I was able to leverage CHATGPT to develop an executive summary for a six-year project with hundreds of activities. Additionally, it helped me rewrite several sections of a poorly crafted report submitted by an expert. The collaboration with CHATGPT not only saved me countless hours of work but also translated into thousands of dollars in saved effort, making the monthly subscription more than worthwhile.

Like any tool, the key to effectively using CHATGPT lies in asking the right questions and refining your queries iteratively. Mastery comes with practice, and the more you use it, the better your results will be.

I hope this article sparks your curiosity to explore AI tools like CHATGPT and enhance your productivity. As the saying goes, AI won’t replace humans, but humans who embrace AI will undoubtedly outpace those who don’t.

The post Discovering the Power of CHATGPT: My Journey with OpenAI’s Innovative AI Tool appeared first on InnoHEALTH magazine.

“Computational study has revealed that dengue antibodies can bind to SARS-CoV-2 receptor-binding domain and vice versa; i.e., SARS-CoV-2 spike antibodies can bind to dengue virus envelope, which further validated dengue virus and SARS-CoV-2 cross-reactivity”, informed the researchers, while talking to India Science Wire.

The study has also shown that SARS-CoV-2 antibodies could cross-neutralize dengue virus serotype1 in virus neutralization test, even with no evidence of dengue pre-exposure. The same was later confirmed for dengue virus serotype2 by scientists from Taiwan. In an invited review article published in the Journal of Medical Virology (Wiley Online Library), the researchers have consolidated all the studies in this area from their lab and other labs worldwide. It was found that antibodies to other pathogens like Plasmodium were also cross-reactive but non-neutralizing for SARS-CoV-2.

The team has tried to present a clear insight into the cross-reactivity of SARS-CoV-2 with dengue, Zika and other pathogens, which are highly mystified with co-infection. “It needs more in-depth investigation towards understanding the disease dynamics and devising strategies of differential diagnosis and treatment management”, says the study team.

The cross-reactivity between dengue virus and SARS-CoV-2 may have varied implications in dengue-endemic countries. Cross-reactivity of dengue virus antibodies may lead to partial neutralization of SARS-CoV-2, thereby reducing the severity of COVID-19. On the other hand, despite the high specificity of the COVID-19 and dengue serological test kits, cross-reactivity issues can lead to false positive results which might lead to misdiagnosis and errors in sero-surveillance for both the viruses.

Clinicians must be well aware of the difference between cross-reaction and co-infection. A wrong diagnosis can be confusing if dengue is mistaken for COVID-19, which tends to increase blood pressure and blood clotting (thrombosis). On the other hand, dengue usually leads to lower blood pressure (due to plasma leakage) and reduced blood clotting (due to a drop in platelet count).The researchers are of the opinion that alternative approaches like SARS-CoV-2 nucleocapsid antibodies could be targeted for diagnosis of COVID-19 in different SARS-CoV-2 serological tests along with virus antigen test or RT-qPCR for virus RNA for a better differential diagnosis.

The researchers caution against false positive results because of this cross-reactivity between dengue and SARS-CoV-2. This is critical since the early symptoms of both diseases overlap, but the treatment/management of the diseases are different. Therefore, clinicians must be cautious and rely on combinations of COVID-19 tests, for instance, using other antibodies (like nucleocapsid)-based sero-diagnosis and/or virus nucleic acid/virus antigen tests. At present, combinations of NS1 antigen ELISA/RT-PCR and serological tests are more reliable options for laboratory diagnosis of dengue.

“Sero-surveillance data for both viruses will be inconclusive since both the viruses cross-react with each other to varying degrees. This is particularly relevant for countries like India, where both the diseases are co-endemic now”, informed the researchers. (India Science Wire)

The post Researchers find cross-reactivity of SARS-CoV-2 with other pathogens appeared first on InnoHEALTH magazine.